Trial Profile
An 168 week open label extension trial evaluating radiographic progression through 4 yrs in Etanercept-treated patients with Ankylosing Spondylitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Jul 2018
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 17 Jul 2018 New trial record
- 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism